Bruker Corporation (BRKR)

Market Cap	8.62B
Revenue (ttm)	3.24B
Net Income (ttm)	304.90M
Shares Out	151.60M
EPS (ttm)	2.06
PE Ratio	27.60
Forward PE	22.23
Dividend	$0.20 (0.35%)
Ex-Dividend Date	Dec 2, 2024

Volume	1,256,961
Open	59.58
Previous Close	59.01
Day's Range	56.83 - 59.97
52-Week Range	48.07 - 94.86
Beta	1.17
Analysts	Buy
Price Target	76.00 (+33.62%)
Earnings Date	Feb 11, 2025

About BRKR

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related te...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 4, 2000
• Employees: 9,707
• Stock Exchange: NASDAQ
• Ticker Symbol: BRKR
• Website: https://www.bruker.com

Financial Performance

In 2023, Bruker's revenue was $2.96 billion, an increase of 17.14% compared to the previous year's $2.53 billion. Earnings were $427.20 million, an increase of 44.03%.

Analyst Forecast

According to 13 analysts, the average rating for BRKR stock is "Buy." The 12-month stock price forecast is $76.0, which is an increase of 33.62% from the latest price.

Price Target

$76.0

(33.62% upside)

Analyst Consensus: Buy